Revenue increased 461.3%
Revenue changed +461.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue changed +461.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Inventory / revenue changed -211992 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
SBC / revenue changed -228911 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Stock-based compensation changed -77.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed +1027328 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Inventory changed +20.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Cash & equivalents changed +392.0% from the comparable as-filed period.
Net income changed +11.6% from the comparable as-filed period.
Research & development changed +11.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating income changed +6.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Selling, general & administrative changed +3.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.